Longevity & Anti-Aging Peptides
Research peptides targeting the hallmarks of biological aging: mitochondrial function, NAD+ metabolism, telomere maintenance, thymic regeneration and circadian bioregulation. Our category features the Khavinson school (Epitalon and related tetrapeptides), mitochondrially encoded peptides such as MOTS-c and SS-31, the copper tripeptide GHK-Cu, and NAD+ boosters. These compounds sit at the cutting edge of preclinical longevity research in 2026. Every batch is supplied with a third-party HPLC certificate of analysis from Janoshik Analytical, available per batch on each product page.
All products
Related research
July 25, 2026
Six of Seven: The Complete FDA Peptide Vote, the One That Failed, and the Five That Come Next
All seven tallies from the 23 and 24 July 2026 FDA compounding meeting, why emideltide was rejected, and which five peptides face the same panel next.
Read more →
July 24, 2026
What the FDA's Own Scientists Wrote About MOTS-c, Semax, Epitalon and DSIP (July 2026)
We read all four FDA briefing documents from the July 2026 compounding meeting: no human studies for MOTS-c, two weak ones for Semax, a cancer question for Epitalon.
Read more →
July 24, 2026
Blood NAD+ Doubled, Cognition Did Not Move: What the July 2026 Trial Actually Found
A randomised trial raised blood NAD+ 2.08-fold in older adults with mild cognitive impairment and improved no cognitive endpoint. The full evidence check.
Read more →








